NasdaqCM - Nasdaq Real Time Price USD
GlycoMimetics, Inc. (GLYC)
0.1594
-0.0066
(-3.98%)
As of 2:32:30 PM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ANDREWS PATRICIA S Director | Stock Award(Grant) | Dec 29, 2023 | 58,608 |
| GOLDBERG MARK ALAN Director | Stock Award(Grant) | Mar 28, 2024 | 36,325 |
| HAHN BRIAN M Chief Financial Officer | Purchase | Jun 18, 2024 | 70,643 |
| INVUS PUBLIC EQUITIES ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale | Jul 30, 2024 | -- |
| JUNIUS DANIEL M Director | Stock Award(Grant) | Mar 28, 2024 | 98,459 |
| KING RACHEL K Director | Stock Award(Grant) | Mar 28, 2024 | 659,095 |
| ROCK EDWIN Officer | Purchase | Jun 21, 2024 | 680,403 |
Related Tickers
EQ Equillium, Inc.
0.3472
-10.11%
ABP Abpro Corporation
0.2104
-13.90%
EYEN Eyenovia, Inc.
2.4250
-9.18%
WINT Windtree Therapeutics, Inc.
0.5827
-3.53%
ONCO Onconetix, Inc.
4.9068
-22.44%
PLRZ Polyrizon Ltd.
0.8310
-22.34%
CYCC Cyclacel Pharmaceuticals, Inc.
0.4013
+11.78%
KAPA Kairos Pharma, Ltd.
0.5190
-8.98%
ELAB PMGC Holdings Inc.
2.1200
-2.30%
PYPD PolyPid Ltd.
3.4600
+0.87%